MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, NEUE made $209,082K in revenue. -$23,501K in net income. Net profit margin of -11.24%.

Income Overview

Revenue
$209,082K
Net Income
-$23,501K
Net Profit Margin
-11.24%
EPS
-$2.62
Unit: Thousand (K) dollars
Revenue Breakdown
    • Aco reach revenue
    • Revenue-Capitated Revenue
    • Revenue-Service Revenue
    • Investment income

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-06-30
2024-09-30
2024-06-30
Total revenue
209,082 232,933 225,991
Operating costs
44,860 64,075 70,217
Restructuring charges
--239
Bad debt expense
-3 14
Medical costs
146,410 182,693 177,681
Intangible assets impairment
0 -11,411
Depreciation and amortization
3,555 3,504 3,978
Total operating expenses
194,825 250,275 263,540
Operating income (loss)
14,257 -17,342 -37,549
Interest expense
6,878 5,413 4,110
Gain on troubled debt restructuring
0 --
Warrant expense (income)
562 459 -2,213
Income (loss) from continuing operations before income taxes
6,817 -23,214 -39,446
Income tax (benefit) expense
-21 2,793 -187
Net income (loss) from continuing operations
6,838 -26,007 -39,259
Loss from discontinued operations, net of tax
-8,386 -14,358 -18,439
Net loss
-1,548 -40,365 -57,698
Series a and b preferred stock dividend accrued
-10,667 10,422
Net income from continuing operations attributable to noncontrolling interests
8,507 17,049 932
Series a and b preferred stock dividend accrued-Series BPreferred Stock
2,465 --
Series a and b preferred stock dividend accrued-Series APreferred Stock
10,981 --
Net loss attributable to neuehealth, inc. common shareholders
-23,501 -70,475 -71,390
Basic weighted-average common shares outstanding (in shares)
8,978,000 8,282,000 8,253,000
Diluted weighted-average common shares outstanding (in shares)
8,978,000 8,282,000 8,253,000
Net loss per share attributable to common stockholders, basic (in dollars per share)
-2.62 -8.51 -8.65
Net loss per share attributable to common stockholders, diluted (in dollars per share)
-2.62 -8.51 -8.65
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Investment income$791K Revenue-Capitated Revenue$82,532K Revenue-Service Revenue$10,420K Aco reach revenue$115,339K Total revenue$209,082K Operating income (loss)$14,257K Total operatingexpenses$194,825K Net lossattributable to neuehealth,...-$23,501K Income tax (benefit)expense-$21K Income (loss) fromcontinuing operations...$6,817K Warrant expense(income)$562K Interest expense$6,878K Depreciation andamortization$3,555K Medical costs$146,410K Operating costs$44,860K Series a and b preferredstock dividend...$10,981K Series a and b preferredstock dividend...$2,465K Net income fromcontinuing operations...$8,507K Net loss-$1,548K Net income (loss)from continuing...$6,838K Loss fromdiscontinued operations, net...-$8,386K

NeueHealth, Inc. (NEUE)

NeueHealth, Inc. (NEUE)